Lurasidone in the treatment of schizophrenia: a critical evaluation

Efficacy of lurasidone across five symptom dimensions of schizophrenia: Pooled analysis of short-term, placebo-controlled studies

(2015) A. Loebel et al.   EUROPEAN PSYCHIATRY

Unmet Needs in the Treatment of Schizophrenia

(2014) Leslie Citrome   JOURNAL OF CLINICAL PSYCHIATRY

Poster #T233 A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF LURASIDONE FOR THE MAINTENANCE OF EFFICACY IN PATIENTS WITH SCHIZOPHRENIA

(2014) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Unmet needs in the management of schizophrenia

(2014) Francisco Torres-González et al.   Neuropsychiatric Disease and Treatment

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

(2013) Leslie Citrome et al.   CNS SPECTRUMS

Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension

(2013) Philip D. Harvey et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Effect of food on the pharmacokinetics of lurasidone: results of two randomized, open-label, crossover studies

(2013) Sheldon Preskorn et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Effectiveness of Lurasidone for Patients With Schizophrenia Following 6 Weeks of Acute Treatment With Lurasidone, Olanzapine, or Placebo

(2013) Stephen M. Stahl et al.   JOURNAL OF CLINICAL PSYCHIATRY

Effectiveness of Lurasidone in Patients with Schizophrenia or Schizoaffective Disorder Switched From Other Antipsychotics

(2013) Joseph P. McEvoy et al.   JOURNAL OF CLINICAL PSYCHIATRY

Lurasidone for the treatment of acutely psychotic patients with schizophrenia: A 6-week, randomized, placebo-controlled study

(2013) Henry A. Nasrallah et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Efficacy and safety of lurasidone 80mg/day and 160mg/day in the treatment of schizophrenia: A randomized, double-blind, placebo- and active-controlled trial

(2013) Antony Loebel et al.   SCHIZOPHRENIA RESEARCH

Effectiveness of lurasidone vs. quetiapine XR for relapse prevention in schizophrenia: A 12-month, double-blind, noninferiority study

(2013) Antony Loebel et al.   SCHIZOPHRENIA RESEARCH

Attenuated psychosis syndrome in DSM-5

(2013) Ming T. Tsuang et al.   SCHIZOPHRENIA RESEARCH

Definition and description of schizophrenia in the DSM-5

(2013) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5

(2013) Deanna M. Barch et al.   SCHIZOPHRENIA RESEARCH

Structure of the psychotic disorders classification in DSM‐5

(2013) Stephan Heckers et al.   SCHIZOPHRENIA RESEARCH

Lurasidone

(2012) Mark Sanford   CNS DRUGS

Long-term safety and tolerability of lurasidone in schizophrenia

(2012) Leslie Citrome et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

(2012) Masaaki Ogasa et al.   PSYCHOPHARMACOLOGY

DSM-5 Status of Psychotic Disorders: 1 Year Prepublication

(2012) R. Tandon et al.   SCHIZOPHRENIA BULLETIN

Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study

(2011) Herbert Y. Meltzer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder

(2011) Steven G. Potkin et al.   SCHIZOPHRENIA RESEARCH

Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone

(2011) Philip D. Harvey et al.   SCHIZOPHRENIA RESEARCH

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia

(2010) John M. Kane et al.   JOURNAL OF CLINICAL PSYCHIATRY

Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future

(2010) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Lurasidone: a new drug in development for schizophrenia

(2009) Jonathan M Meyer et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Lurasidone in the Treatment of Acute Schizophrenia

(2009) Mitsutaka Nakamura et al.   JOURNAL OF CLINICAL PSYCHIATRY